Rhumbline Advisers Reduces Position in SWK Holdings Co. (NASDAQ:SWKH)

Rhumbline Advisers lessened its holdings in shares of SWK Holdings Co. (NASDAQ:SWKH) by 14.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,024 shares of the company’s stock after selling 834 shares during the period. Rhumbline Advisers’ holdings in SWK were worth $80,000 at the end of the most recent reporting period.

Other large investors have also recently modified their holdings of the company. Barclays PLC raised its stake in SWK by 185.0% in the third quarter. Barclays PLC now owns 4,461 shares of the company’s stock worth $77,000 after buying an additional 2,896 shares in the last quarter. JPMorgan Chase & Co. increased its position in shares of SWK by 224.4% during the third quarter. JPMorgan Chase & Co. now owns 6,108 shares of the company’s stock worth $106,000 after purchasing an additional 4,225 shares in the last quarter. Grace & White Inc. NY increased its position in shares of SWK by 11.1% during the fourth quarter. Grace & White Inc. NY now owns 18,721 shares of the company’s stock worth $297,000 after purchasing an additional 1,871 shares in the last quarter. SkyView Investment Advisors LLC increased its position in shares of SWK by 2.1% during the third quarter. SkyView Investment Advisors LLC now owns 31,815 shares of the company’s stock worth $550,000 after purchasing an additional 650 shares in the last quarter. Finally, Victory Capital Management Inc. acquired a new position in shares of SWK during the third quarter worth $589,000. Hedge funds and other institutional investors own 99.27% of the company’s stock.

SWK Stock Performance

Shares of SWKH stock opened at $16.46 on Tuesday. The business’s fifty day simple moving average is $16.51 and its 200-day simple moving average is $16.58. The company has a market cap of $201.36 million, a PE ratio of 17.70 and a beta of 0.40. The company has a current ratio of 5.06, a quick ratio of 5.06 and a debt-to-equity ratio of 0.11. SWK Holdings Co. has a 12-month low of $15.14 and a 12-month high of $18.49.

SWK Profile

SWK Holdings Corporation, offers specialty finance and asset management services in the United States. It operates in two segments, Finance Receivables and Pharmaceutical Development. The Finance Receivables segment provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors.